SCYNEXIS, Inc.
SCYNEXIS, Inc. (SCYX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SCYX · as of Jun 9, 2026
Key Statistics
Explore SCYNEXIS, Inc. Data
scyx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 92.9%
Competitors & Peers
scyx competitorsSCYX
CLGN
COSM
CVKD
KLTO
NRSNStock Performance
Full HistoryAbout SCYNEXIS, Inc.
SCYNEXIS, Inc. is a biotechnology firm based in the U.S. dedicated to developing therapies for fungal infections. The company's flagship product, BREXAFEMME (ibrexafungerp tablets), has received appro…
what is scynexis, inc. · scyx stock overview · scynexis, inc. company profile · who is scynexis, inc. ceo · scyx NASDAQ · scynexis, inc. headquarters · scynexis, inc. business segments
About Stock Overview & Key Data
SCYNEXIS, Inc. (SCYX) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since May 2, 2014. As of the latest trading session, SCYX stock price is $4.45, with a market capitalization of $28.0M. The stock has returned -35.32% over the past 12 months and -12.06% year-to-date.
According to 14 Wall Street analysts, the consensus rating for SCYNEXIS, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, SCYNEXIS, Inc. reported revenue of $20.6M and net income of -$8.6M. For detailed data — including SCYNEXIS, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, SCYNEXIS, Inc. (SCYX) stock price is $4.45. The stock is traded on NASDAQ under the ticker symbol SCYX. The 52-week range is $4.45 – $10.48.